VIDEO: Annual flu, COVID and RSV vaccines among most recommended by PCP. Video 2. 01:31. VIDEO: Building trust with patients key to dispelling vaccine misinformation. Video 3. 03:15.

Flu, COVID-19, and Respiratory Syncytial Virus (RSV): If you are ill with a respiratory virus, PLEASE STAY HOME and away from others. This will help everyone. If you are in the clinical portion of ...

Moderna receives US FDA approval for RSV vaccine, mResvia, in adults aged 18-59 at increased risk for RSV disease. News release. Moderna. June 12, 2025.

Fiona Havers, a physician considered a senior subject-matter expert on respiratory diseases and vaccines, led the CDC’s surveillance of hospitalizations for coronavirus and respiratory syncytial ...

The researchers noted demographic and illness characteristics were similar between patients with RSV type A and those with RSV type B. The estimated overall seasonal incidence of outpatient ...

Moderna's RSV vaccine gets expanded approval for 18-59 year olds at high risk of severe illness, marking a significant step in vaccine protection. The Food and Drug Administration (FDA) expanded the ...

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to 59 years old who are at increased risk for severe illness from ...

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to 59 years old who are at increased risk for severe illness from ...

Moderna's RSV vaccine gets expanded approval for 18-59 year olds at high risk of severe illness, marking a significant step in vaccine protection. The Food and Drug Administration (FDA) expanded the ...

Moderna's RSV vaccine gets expanded approval for 18-59 year olds at high risk of severe illness, marking a significant step in vaccine protection. The Food and Drug Administration (FDA) expanded the ...

Later this month, HHS Secretary Robert F. Kennedy Jr.'s revamped CDC vaccine advisory committee will discuss RSV vaccination guidelines for the newly approved patient group, high-risk adults 18 ...